View Older Stories View More Recent Stories

May 1, 2025 06:49AM Eli Lilly & Co. (LLY) Misses Q1 EPS by 12c; updates guidance
May 1, 2025 04:00AM Eli Lilly faces Q1 sales headwinds as incretin gains offset by weakness in other drugs
Apr 30, 2025 10:27AM Eli Lilly & Co. (LLY) call put ratio 1 call to 1.2 puts into quarter results
Apr 30, 2025 05:53AM Eli Lilly & Co. (LLY) May 2 weekly 885 straddle priced into quarter results
Apr 29, 2025 11:21AM Eli Lilly & Co. (LLY) call put ratio 1.7 calls to 1 put into quarter results
Apr 29, 2025 08:41AM Hims & Hers shares surge over 40% on Wegovy pact with Novo Nordisk
Apr 28, 2025 02:12PM Eli Lilly & Co. (LLY) option implied volatility flat into quarter results
Apr 28, 2025 11:34AM HSBC cuts biotech stocks: Eli Lilly lowered to Reduce
Apr 28, 2025 06:22AM Goldman Sachs Reiterates Buy Rating on Eli Lilly (LLY)
Apr 28, 2025 03:24AM HSBC Downgrades Eli Lilly (LLY) to Reduce
Apr 22, 2025 08:11AM Cantor Fitzgerald Reiterates Overweight Rating on Eli Lilly (LLY)
Apr 22, 2025 08:04AM Bernstein on Eli Lilly (LLY): 'Our Top Pick Still Holds'
Apr 22, 2025 07:21AM Cantor Fitzgerald Starts Eli Lilly (LLY) at Overweight
Apr 21, 2025 10:58AM BMO Capital: 'Eli Lilly (LLY) Positions Orforglipron for a Global Launch'
Apr 17, 2025 03:12PM Eli Lilly & Co. (LLY) call put ratio 1.1 calls to 1 put as share price up 15.9%
Apr 17, 2025 10:57AM Eli Lilly (LLY) PT Lowered to $900 at BMO Capital
Apr 17, 2025 10:25AM Eli Lilly & Co. (LLY) call put ratio 1.4 calls to 1 put as share price up 13%
Apr 17, 2025 09:19AM Leerink Partners Reiterates Outperform Rating on Eli Lilly (LLY)
Apr 17, 2025 07:33AM Eli Lilly shares jump 12% on positive Phase 3 results for oral diabetes drug
Apr 17, 2025 06:54AM Eli Lilly & Co. (LLY) Shares Up 13% on GLP-1 Study Update, Trading 832 Handle
Apr 17, 2025 06:50AM Eli Lilly & Co. (LLY) oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial
Apr 15, 2025 10:49AM Bernstein: 'Eli Lilly (LLY) Keeps Taking Share'
Apr 9, 2025 09:19AM Pharma stocks slide after Trump signals tariffs on sector
Apr 8, 2025 05:08AM Goldman Sachs Upgrades Eli Lilly (LLY) to Buy
Apr 7, 2025 06:38AM BofA: 'Weekly GLP-1 TRx growth in March is trending slightly ahead of February'
Apr 4, 2025 04:23PM Trump Admin Drops Biden Medicare Obesity Drug Coverage Proposal - Bloomberg
Apr 1, 2025 04:00PM BofA highlights 10 stocks to own for Q2
Apr 1, 2025 01:31PM Hims & Hers Health (HIMS) expanding access to personalized weight loss care
Apr 1, 2025 01:04PM Hims & Hers Health, Inc. (HIMS) said to sell Lilly's Zepbound
Apr 1, 2025 09:33AM Bernstein Assesses U.S. Biopharma Stocks Amid Tariff Risks
Apr 1, 2025 06:17AM Wells Fargo Releases Regular Quarterly Update to Tactical Ideas List
Mar 31, 2025 04:57AM Stocks expected to have increasing option volume: LLY NVO TEM SPY QQQ
Mar 28, 2025 07:19AM Lilly's (LLY) Kisunla Fails To Get Eu Approval In Early Alzheimer's
Mar 28, 2025 06:40AM Eli Lilly & Co. (LLY) call put ratio 1 call to 1.3 puts
Mar 27, 2025 08:06AM Organovo (ONVO) Provides Business Update
Mar 26, 2025 06:00PM Weighing in on obesity: Catalyst-rich 2025 ahead in a growing competitive landscape
Mar 26, 2025 09:45AM Truist Weighs In on Obesity: 'Catalyst-Rich 2025 Ahead in a Growing Competitive Landscape'
Mar 25, 2025 11:28AM Organovo (ONVO) Announces Close of the Sale of FXR Program to Eli Lilly and Company (LLY)
Mar 25, 2025 10:12AM Bernstein on Eli Lilly (LLY): 'We Like the Lead that Retatrutide Has'
Mar 24, 2025 12:54PM Investment commitments in U.S. nears $3 trillion since Trump took office
Mar 24, 2025 10:17AM Jefferies Reiterates Buy Rating on Eli Lilly (LLY)
Mar 24, 2025 09:00AM UBS Reiterates Buy Rating on Eli Lilly (LLY)
Mar 18, 2025 07:57AM Bernstein on Eli Lilly (LLY): 'LLY Takes Majority Share & Anti-Cancer Potential for Retatrutide'
Mar 18, 2025 06:52AM Cantor Fitzgerald says more options, newer targets will expand obesity market
Mar 16, 2025 10:00AM Will Pfizer step into the obesity ring? Wolfe Research answers
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Mar 15, 2025 04:00AM How could tariffs shake up the pharma sector?
Mar 10, 2025 08:02AM Morgan Stanley Reiterates Overweight Rating on Eli Lilly (LLY)
Mar 7, 2025 08:32AM Eli Lilly's (LLY) EBGLYSS single monthly maintenance injection achieved completely clear skin at three years in half of patients with moderate-to-severe atopic dermatitis
Mar 6, 2025 08:52AM Teladoc (TDOC) +2% on addition of GLP-1 self-pay option with Lilly
View More Recent Stories View Older Stories